✦ LIBER ✦

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study*1

✍ Scribed by LINDOR, K

Book ID: 121941569
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 545 KB
Volume: 22
Category: Article
ISSN: 0270-9139
DOI: 10.1016/0270-9139(95)90624-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combination of ursodeoxycholic acid

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study

✍ Keith D. Lindor; E. Rolland Dickson; Roberta A. Jorgensen; Monte L. Anderson; Ru 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Ursodeoxycholic acid (UDCA) and methotrexate (MTX) have both been proposed as treatments for patients with primary biliary cirrhosis (PBC). It has been suggested that a combination of the two drugs may offer advantages over either used separately. In this pilot study, we sought to evaluate the safet

The combination of ursodeoxycholic acid

The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone

✍ Alvaro González-Koch; Javier Brahm; Cristina Antezana; Gladys Smok; Miguel A. Cu 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 785 KB

Pilot study: fenofibrate for patients wi

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

The efficacy of ursodeoxycholic acid and

The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study

✍ Shinji Iwasaki; Hiromasa Ohira; Shuhei Nishiguchi; Mikio Zeniya; Shuichi Kaneko; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Methotrexate (MTX) plus ursodeoxycholic

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis

✍ Burton Combes; Scott S. Emerson; Nancy L. Flye; Santiago J. Munoz; Velimir A. Lu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

This placebo-controlled, randomized, multicenter trial compared the effects of MTX plus UDCA to UDCA alone on the course of primary biliary cirrhosis (PBC). Two hundred and sixty five AMA positive patients without ascites, variceal bleeding, or encephalopathy; a serum bilirubin less than 3 mg/dL; se

Methotrexate therapy for the symptomatic

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy

✍ M. A. BABATIN; F. M. SANAI; M. G. SWAIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB